Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

NCT06365788 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Neoplasms

Interventions

DRUG: Abemaciclib
DRUG: Bicalutamide

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]
[object Object]
[object Object]